Beyond Antivirals: Alternative Therapies for Long COVID
Viruses · 2024
DOI: 10.3390/v16111795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Achilleas Livieratos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, 15238 Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) is a condition characterized by numerous lingering symptoms that persist for weeks to months following the viral illness. While treatment for PASC is still evolving, several therapeutic approaches beyond traditional antiviral therapies are being investigated, such as immune-modulating agents, anti-inflammatory drugs, and various supportive interventions focusing at alleviating symptoms and enhancing recovery. We aimed to summarize the breadth of available evidence, identify knowledge gaps, and highlight promising non-antiviral therapies for Long COVID/PASC. We followed the framework of a scoping methodology by mapping existing evidence from a range of studies, including randomized clinical trials, observational research, and case series. Treatments evaluated include metformin, low-dose naltrexone (LDN), dexamethasone, statins, omega-3 fatty acids, L-arginine, and emerging therapies like intravenous immunoglobulin (IVIg) and therapeutic apheresis. Early findings suggest that metformin has the strongest clinical evidence, particularly from large phase 3 trials, while LDN and dexamethasone show potential based on observational studies. However, many treatments lack robust, large-scale trials. This review emphasizes the need for further research to confirm the efficacy of these treatments and guide clinical practice for Long COVID management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Independent Researcher, 15238 Athens, Greece.
- Department of Medicine, University of Patras, 26504 Rio, Greece.
- Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.
ORCID-Profile: Karolina Akinosoglou
Zitieren
APA
Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Beyond Antivirals: Alternative Therapies for Long COVID. Viruses. https://doi.org/10.3390/v16111795
Vancouver
Livieratos A, Gogos C, Akinosoglou K. Beyond Antivirals: Alternative Therapies for Long COVID. Viruses. 2024. doi:10.3390/v16111795
BibTeX
@article{Livieratos2024,
author = {Livieratos, Achilleas and Gogos, Charalambos and Akinosoglou, Karolina},
title = {Beyond Antivirals: Alternative Therapies for Long COVID},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16111795}
}
EUVIMED